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The Na+/glucose cotransporter (SGLT1) is an archetype for the SLC5 family, which is comprised of Na+-coupled 
transporters for sugars, myo-inositol, choline, and organic anions. Application of the reducing agent dithriothrei-
tol (DTT, 10 mM) to oocytes expressing human SGLT1 affects the protein’s presteady-state currents. Integration 
of these currents at different membrane potentials (Vm) produces a Q-V curve, whose form was shifted by +25 mV 
due to DTT. The role of the 15 endogenous cysteine residues was investigated by expressing SGLT1 constructs, 
each bearing a single mutation for an individual cysteine, in Xenopus oocytes, using two-microelectrode voltage-
clamp electrophysiology and fl  uorescent labeling. 12 of the 15 mutants were functional and could be separated 
into three distinct groups based on the effect of the mutation on the Q-V curve: four mutants did not perturb the 
transferred charge, six mutants shifted the Q-V curve towards negative potentials, and two mutants (C255A and 
C511A) produced a shift in the positive direction that was identical to the shift produced by DTT on the wild-type 
(wt) SGLT1. The double mutant C255,511A confi  rms that the effects of each single mutant on the Q-V curve were not 
additive. With respect to wt SGLT1, the apparent affi  nities for α-methylglucose (αMG) were increased in a similar 
manner for the single mutants C255A and C511A, the double mutant C255,511A as well as for wt SGLT1 treated with 
DTT. When exposed to a maleimide-based fl  uorescent probe, wt SGLT1 was not signifi  cantly labeled but mutants 
C255A and C511A could be clearly labeled, indicating an accessible cysteine residue. These residues are presumed 
to be C511 and C255, respectively, as the double mutant C255,511A could not be labeled. These results strongly 
  support the hypothesis that C255 and C511 form a disulfi  de bridge in human SGLT1 and that this disulfi  de bridge 
is involved in the conformational change of the free carrier.
INTRODUCTION
The Na+/glucose cotransporter SGLT1, responsible for 
intestinal absorption and renal reabsorption of glucose, 
was fi  rst postulated by Crane four decades ago (Crane, 
1965). In 1987, the cDNA of a fi  rst Na+/glucose co-
transporter was cloned from rabbit small intestine 
  (Hediger et al., 1987), which has enabled detailed char-
acterization using expression in Xenopus oocytes with 
two-electrode voltage-clamp and cut-open oocyte elec-
trophysiology. Exploration of steady-state and presteady-
state kinetics (i.e., phlorizin-sensitive presteady-state 
currents) led to a simple kinetic model explaining li-
gand binding and conformational changes but the 
identifi  cation of the amino acids forming the actual 
binding sites for Na+, glucose, and phlorizin (Pz) is 
still a matter of some debate (Parent et al., 1992a,b; 
  Panayotova-Heiermann et al., 1994; Chen et al., 1995; 
Panayotova-Heiermann et al., 1995, 1996; X.Z. Chen 
et al., 1996, 1997; Wright et al., 1998; Lo and Silverman, 
1998a; Wright and Turk, 2004).
Cysteine residues involved in disulfi  de bridges gener-
ally play an important role in stabilizing a protein’s 
three dimensional structure. Studies identifying essen-
tial cysteine and potential disulfi  de bridges in trans-
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porters have been performed in the past and have led 
to the identifi  cation of some initial three dimensional 
constraints, which are generally diffi  cult to obtain for 
membrane proteins (van Iwaarden et al., 1991; Sahin-
Toth et al., 1994; J.G. Chen et al., 1997; Sur et al., 1997; 
Lambert et al., 2000a,b, 2001; Kohler et al., 2003; Murer 
et al., 2004). In some studies, cysteine replacements 
were shown to affect the correct traffi  cking or stability 
of the protein in the plasma membrane but there was 
no evidence that this effect implied breaking of a disul-
fi  de bridge (J.G. Chen et al., 1997; Sur et al., 1997; Pajor 
et al., 1999; Tanaka et al., 2004).
The effect of the reducing agent dithiothreitol (DTT) 
on Na+/glucose cotransport (probably via SGLT2) was 
explored in 1983 on rabbit renal outer cortical brush 
border membranes (Turner and George, 1983, 1984) 
and the authors proposed that at least two disulfi  de 
bridges were important for Pz binding. Unfortunately, 
no extensive mutagenesis study on the endogenous cys-
teine residues of SGLT1 (or SGLT2) has been pub-
lished. However, a few observations suggest important 
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roles for some cysteine residues in SGLT1 (Martin et al., 
1996; Wright, 1998; Xia et al., 2003, 2004). The muta-
tions C292Y or C355S in human SGLT1 produce the 
hereditary disease glucose-galactose malabsorption syn-
drome (Martin et al., 1996; Wright, 1998). Cysteines in 
positions 560 and 608 (in rabbit SGLT1) have been pro-
posed to form a disulfi  de bridge in the purifi  ed isolated 
loop between the last two transmembrane segments 
(Xia et al., 2003, 2004). Recently, the mutations C351A 
and C361A have been shown to impair proper traffi  ck-
ing to the plasma membrane that was, however, present 
in the double mutant (C351A/C361A) (Xia et al., 
2005). Finally, endogenous cysteine residues in SGLT1 
have been shown to be insensitive to alkylation by NEM 
or MTS reagents, which suggests that they are either 
physically inaccessible or involved in disulfi  de bridges 
(Loo et al., 1998; Lo and Silverman, 1998a; Gagnon 
et al., 2005).
The aim of the present study is to identify the cysteine 
residues involved in the functional effects caused by 
treating SGLT1 with DTT, using mutagenesis, electro-
physiology, and fl  uorescent labeling after expressing 
SGLT1 mutants in Xenopus oocytes. We mutated each 
endogenous cysteine residue individually into an ala-
nine residue. Our results indicate that cysteine residues 
C255 and C511 form a disulfi  de bridge in SGLT1, which 
explains the effect of DTT on SGLT1. To our knowl-
edge, the identifi  cation of this disulfi  de bridge repre-
sents the fi  rst three-dimensional constraint to the simple 
membrane topology proposed for SGLT1.
MATERIALS AND METHODS
Molecular Biology
Mutant forms of SGLT1 were constructed using the human Na+/
glucose cotransporter with an NH2-terminal myc epitope in ex-
pression vector pBS (pBS-myc-hSGLT1) (Bissonnette et al., 
1999). Site-directed mutations were created following the method 
of Fisher and Pei (1997) and were confi  rmed by dideoxy DNA se-
quencing (Sheldon Biotechnology). QIAGEN mini-prep kits 
were used to extract DNA, and after EcoR1 digestion, the cDNA 
insert was transcribed in vitro using the T3 mMessage mMachine 
kit (Ambion).
Oocyte Preparation and Injection
Oocytes were surgically removed from Xenopus laevis frogs, dis-
sected, and defolliculated as described previously (Bissonnette 
et al., 1999; Gagnon et al., 2004). 1 d after defolliculation, oocytes 
were injected with 46 nl of mRNA solution (0.1 and 0.25 μg/μl 
for wt SGLT1 and mutants, respectively) in order to obtain maxi-
mal protein expression. Oocytes were maintained in Barth’s solu-
tion (in mM: 90 NaCl, 3 KCl, 0.82 MgSO4, 0.41 CaCl2, 0.33 
Ca(NO3)2, 5 HEPES, pH 7.6) supplemented with 5% horse se-
rum, 2.5 mM Na+-pyruvate, 100 U/ml penicillin, and 0.1 mg/ml 
streptomycin for 4–7 d before being used in an experiment.
Electrophysiology
The saline solution normally used in our electrophysiological ex-
periments is composed of (in mM) 90 NaCl, 3 KCl, 0.82 MgCl2, 
0.74 CaCl2, 10 HEPES, and the pH was adjusted to 7.6 with NaOH. 
Two electrode voltage-clamp experiments were performed using 
an Oocyte Clamp OC-725 (Warner Instrument Corp.) and a data 
acquisition system (Digidata 1322A and Clampex 8.2; Axon In-
struments Inc.). Current and voltage microelectrodes were fi  lled 
with 1 M KCl and had a resistance of 2–5 MΩ. The bath current 
electrode was a Ag-AgCl pellet, and the reference electrode was a 
1 M KCl agar bridge. The oocytes were clamped to a membrane 
potential of −50 mV, and three repetitions of membrane poten-
tial steps between +70 and −170 mV (by increments of 20 mV, 
300 ms duration, no series resistance compensation used) were 
applied with an interval of 1.7 s between each step. Data was ob-
tained with a sampling frequency of 10 kHz and the three repeti-
tions were averaged for each experiment. DTT (Sigma-Aldrich) 
treatments were performed by exposing oocytes for 20–30 min at 
their resting potential to 2.5 mM DTT for steady-state mea-
surements (α-methyl-glucose [αMG] affi  nity measurements) or to 
10 mM for presteady-state and Na+ leak measurements. As the 
  effects of DTT were rapidly reversible, DTT was also present in 
all experimental solutions after the initial treatment.
Data Analysis
Current versus membrane potential curves (I-V curves) were ob-
tained by averaging the current data points at the end of each 
membrane potential step (between 150 and 300 ms, except for 
mutants in Group B [see below], which were measured between 
250 and 300 ms). Determination of apparent affi  nity for αMG 
(Km
αMG) was done as described before (Bissonnette et al., 1999). 
Using the same pulse protocol, presteady-state current analysis 
(Q-V curves) was performed by subtracting the integrated base-
line-corrected currents in phlorizin solution (200 μM) from simi-
lar currents in saline solution. In general, the correction for 
steady-state currents was done by removing the mean current 
measured between 50 and 80 ms after the initiation of a voltage 
pulse. This was done in order to minimize the contribution of 
slower time-dependent increases in measured current that were 
sometimes observed at extreme membrane potentials. For some 
mutated proteins that presented signifi  cantly slower presteady-
state currents, as compared with wt SGLT1 (Group B), the mean 
currents were taken at the end of the pulse (from 270 to 300 ms). 
A simple Boltzmann equation was fi  tted to the Q-V curve to esti-
mate V1/2 (the voltage at which half of the charge is transferred), 
Qmax (the amplitude of the total charge transferred), and z (the 
valence of the transferred charge) (Bissonnette et al., 1999). The 
time constants were evaluated by fi  tting a double exponential on 
the Itransit (Isaline − IPz) with the Clampfi  t 8.2 program (Axon Instru-
ments Inc.).
Modeling of Presteady-state Currents
The presteady-state current time constants and transferred 
charges were calculated using a four-state kinetic model that we 
have proposed in a previous publication (Chen et al., 1996) (see 
Appendices A and B and discussion for details). The numerical 
simulations were performed using Matlab 6.5.0 software (The 
Math Works Inc.). The transferred charges were analyzed by fi  t-
ting a Boltzmann curve to the calculated data in order to extract 
the V1/2 and z parameters. The parameters of the model were ad-
justed by trial and error to obtain a satisfactory fi  t to the measured 
V1/2 and the slow time constants of the presteady-state currents.
Plasma Membrane Preparation of Oocytes and Western 
Blot Detection
Preparation of enriched plasma membrane fractions from oocytes 
and Western blot detection were performed as previously de-
scribed (Bissonnette et al., 1999). In brief, 20 oocytes were rinsed 
and then homogenized in 1.5 ml homogenization solution (50 mM 
mannitol, 2 mM Tris, 5 mM EGTA supplemented with a protease 
inhibitor cocktail [Sigma-Aldrich], pH 7.0). Three consecutive Gagnon et al. 147
centrifugations were performed (2 × 10 min at 1,000 g and 
1 × 20 min at 10,000 g, at 4°C), and the fi  nal pellet was resus-
pended in 10 μl of homogenization solution. 10 μl of Laemmli 
solution was added and the samples were loaded onto SDS-poly-
acrylamide gels for electrophoresis. The quality of transfer onto 
nitrocellulose was verifi  ed using Ponceau red staining. For West-
ern blots, the membrane was blocked against nonspecifi  c binding 
(5% fat milk in TBS, 1 h at room temperature) and then incu-
bated with the primary antibody (anti-myc, 1:500 in blocking solu-
tion, overnight at 4°C). The membrane was washed, blocked 
again, and then incubated with the secondary antibody (HRP-
conjugated anti–mouse IgG, 1:1,000 in blocking solution) at 
room temperature for 1 h. After fi  nal washing steps, blots were re-
vealed by enhanced chemiluminescence detection (Phototope-
HRP; New England Biolabs).
Fluorescence
Fluorescence measurements were done as previously described 
(Gagnon et al., 2005). In brief, a 5–10 min fl  uorescent labeling 
was performed on ice in a saline solution containing 20 μM tetra-
methylrhodamine-5-maleimide fl  uorescent probe (TMR5M, Mo-
lecular Probes) at the oocyte’s resting potential. Oocytes were 
preincubated 5–10 min on ice before the fl  uorescent probe was 
added. Fluorescence intensity was read, at the animal pole, using 
excitation and emission fi  lters (10 nm bandwidth) centered at 
500 nm and 600 nm, respectively.
Statistics
Experiments were performed on at least three oocytes obtained 
from a minimum of two different donors. Data are reported as 
mean ± SEM (except when otherwise noted) and are com-
pared using unpaired Student’s t test; statistical signifi  cance was 
set at P < 0.05.
RESULTS
DTT Effect on Wild-type SGLT1 Activity
We tested the effects of breaking disulfi  de bridges with 
DTT on steady-state parameters (cotransport current 
due to the addition of 5 mM αMG [Icotr], Na+ leak cur-
rent [Ileak], apparent affi  nities for the sugar substrate 
[Km
αMG]) and on presteady-state currents (Q-V curves) 
of the wt human SGLT1. Prior to DTT treatment, our 
measurements were fully consistent with those previ-
ously published for human SGLT (Parent et al., 1992a,b; 
Loo et al., 1993; Chen et al., 1996; Hirayama et al., 1996; 
Bissonnette et al., 1999). Fig. 1 illustrates the effects of 
DTT on steady-state parameters of wt SGLT1. The re-
ducing treatment was found to decrease Ileak (Fig. 1 B) 
as well as the apparent affi  nities for αMG (panel C) 
without having any signifi  cant effect on Icotr (panel A).
The effect of DTT treatment on the transferred 
charge curve, shown in Fig. 2, demonstrates a clear cut 
shift of +25 mV (see Fig. 2 B) from a V1/2 of −46 ± 3 mV 
under control conditions (n = 9) to −21 ± 1 mV in the 
presence of DTT (n = 6). As shown in Fig. 2 C, the ef-
fects of DTT on the presteady-state currents of wt SGLT1 
are not only to shift the Q-V curve toward more positive 
potentials but also to accelerate the presteady-state cur-
rent. Prior to the DTT treatment, the slow time constant 
of the presteady-state current is observed to plateau at 
10 ms for all hyperpolarizing potentials, whereas in 
DTT the plateau is found around 4.5 ms. This effect 
  requires  20–25 min to be complete, and is completely 
reversible when DTT is removed from bathing solu-
tions (unpublished data). It is clear that the total charge 
transferred and the z parameter (related to the slope 
of the Q-V curve) are not affected by the reducing 
agent, which affects only the V1/2 parameter and the 
time constant.
As the presteady-state currents are thought to origi-
nate from the movement of a charged portion of SGLT1 
in the membrane electric fi  eld and/or from the voltage-
dependent Na+ binding step (Parent et al., 1992a,b), 
we hypothesized that one or more disulfi  de  bridges 
were playing important roles in one or both of these 
steps. The presence of a disulfi  de bridge can be assessed 
by mutating each endogenous cysteine residue, which 
would potentially remove a disulfi  de bridge, and fur-
ther tested by studying double mutants. If a cysteine res-
idue plays an important functional role through a 
disulfi  de bridge, mutating either of the two cysteines in-
volved should produce equivalent effects. In addition, 
mutating a cysteine residue involved in a disulfi  de 
bridge should not produce any effect if its partner cyste-
ine has already been replaced (i.e., comparing a single 
with a double cysteine mutant).
Molecular Biology and Expression of Mutants SGLT1s
Fig. 3 illustrates the position of the 15 endogenous cys-
teine residues present in the human Na+/glucose co-
transporter using a modifi  ed topologic model (Gagnon 
et al., 2005) based on the model originally proposed by 
Turk et al. (1996). Mutants were tested using two micro-
electrode electrophysiology. We fi  rst tested the three 
basic electrophysiological characteristics: Icotr (current 
due to the addition of 5 mM αMG), Ileak (currents in the 
saline solution minus the currents measured in the pres-
ence of 200 μM Pz), and the charge transferred (Q-V).
Of the 15 single mutants generated, only three were 
nonfunctional: C351A, C355A, and C361A. These mu-
tants displayed no presteady-state currents, no Ileak and 
no Icotr. The possibility that the sugar affi  nity could have 
been vastly decreased was investigated by applying 
100 mM αMG to these mutants but still no cotransport 
currents could be detected (n = 3). Through Western blot 
detection against plasma membrane enriched subcellu-
lar fractions of oocytes expressing these mutant pro-
teins, SGLT1 expression could be detected for C351A 
and C361A but not for mutant C355A (Fig. 4). In a few 
experiments, a very weak band could be observed for 
C355A, indicating that the protein was poorly translated 
or generated an unstable product. As preparations en-
riched in plasma membranes may also contain intracel-
lular membranes, the three inactive mutants may have 
been trapped in some intracellular compartments or 
may be present at the plasma membrane but inactive.148 Disulﬁ  de Bridge in SGLT1
the Q-V curve; Group B, which had a shift toward nega-
tive potentials; and Group C, which had a shift toward 
positive potential. These shifts are compared with V1/2 
of the wt SGLT1, which averaged −46 ± 3 mV. Figs. 5–7 
illustrate, for each of the three groups of mutants, the 
amplitude of the αMG cotransport current (Icotr), the 
Na+ leak current (Ileak) at −110 mV (panel A), the Pz-
sensitive presteady-state currents (Isaline − IPz) for a se-
lection of membrane potentials ranging from +70 to 
−170 mV (panel B), and the values of the measured V1/2 
(panel C) for presteady-state currents, i.e., the voltage 
for which the mobile charge is equally balanced between 
inward-facing and outward-facing confi  gurations.
Mutants C317A, C345A, C517A, and C659A form 
Group A (Fig. 5). Aside from mutant C345A, which has 
a very low expression level (Icotr of −107 ± 39 nA, Ileak of 
−13 ± 5 nA, and Qmax of 2.66 ± 0.09 nC, n = 4, see 
Fig. 4 for the detection of C345A in Western blots), the 
expression levels of mutants C317A, C517A, and C659A 
were comparable to that normally reached by wt SGLT1. 
Figure 1.  Effects of DTT exposure on steady-state parameters of 
wt Na+/glucose cotransporter (wt SGLT1). (A) Effect of DTT on 
αMG cotransport current (Icotr) of wt SGLT1. Estimation of the 
currents was done under control conditions (fi  lled symbols) and 
in the presence of DTT (2.5 mM) (open symbols) on each oocyte 
(n = 3, paired experiments). (B) Effect of DTT on Na+ leak cur-
rent (Ileak) of wt SGLT1. A 30-min exposure with 10 mM DTT was 
done before the experimental test of Ileak (done in the presence 
of DTT) (n = 6 for control conditions, fi  lled symbols, n = 5 for 
DTT, open symbols, unpaired experiments). (C) Effect of DTT on 
apparent affi  nity for αMG (Km
αMG) as a function of membrane 
  potential (Vm). Estimation of the apparent affi  nity for αMG was 
done under control conditions (fi  lled symbols) and in the pres-
ence of DTT (2.5 mM) (open symbols) on each oocyte (n = 4, 
paired experiments).
Based on analysis of their presteady-state currents, the 
12 functional mutants could be separated into three cat-
egories: Group A, which exhibited no signifi  cant shift of 
Figure 2.  Effect of DTT exposure on presteady-state parameters 
of wt Na+/glucose cotransporter (wt SGLT1). (A) Presteady-state 
currents (Pz-sensitive currents in the absence of glucose) of a 
typical oocyte expressing wt SGLT1 under control conditions 
and after exposure to DTT (30 min preincubation with 10 mM 
DTT, with DTT present in subsequent experimental solutions). 
(B) Effect of DTT on transferred charges (Q-V curve) of wt 
SGLT1. Q-V curves were fi  tted with a Boltzmann equation (see 
MATERIALS AND METHODS), adjusted to 0 at hyperpolarizing 
voltages and normalized with respect to the extrapolated Qmax 
(n = 9 for control conditions, fi  lled symbols, n = 6 for DTT, open 
symbols, unpaired experiments). (C) Time constant of the 10-ms 
component of presteady-state currents of wt SGLT1 compared 
with wt + DTT. The curves represent the time constants evaluated 
with a four-state model of presteady-state currents with parame-
ters described in Table I.Gagnon et al. 149
The V1/2 of these four mutants ranged between −40 
and −56 mV and, aside from the V1/2 for mutant C659A, 
were not signifi  cantly different from the V1/2 for wt 
SGLT1. Mutant C659A had a V1/2 of −56 ± 2 mV (n = 5) 
and was barely more negative than that of wt SGLT1 
(P = 0.011), but because of the small difference and the 
considerable variability normally observed within a se-
ries of measurements of V1/2, mutant C659A was classi-
fi  ed into Group A.
Group B (Fig. 6) is composed of single mutants that 
have a V1/2 shifted toward negative membrane poten-
tials as compared with that of wt SGLT1. The V1/2 values 
for mutants C292A, C301A, C314A, C522A, C560A, and 
C610A were measured at −84 ± 4 (n = 7), −81 ± 2 
(n = 6), −66 ± 2 (n = 7), −67 ± 4 (n = 7), −75 ± 3 
(n = 6) and −121 ± 6 (n = 6) mV, respectively. As ob-
served for three of the Group A mutants, mutants 
C301A, C314A, and C610A display Icotr and Ileak values 
quite comparable to those for wt SGLT1. Mutants C522A 
and C560A were both characterized by a reduced Icotr 
(−174 ± 29 nA and −307 ± 43 nA, respectively), which 
might be caused by a low expression level as their Qmax 
(2.7 ± 0.2 and 9.2 ± 0.5 nC, respectively) values were also 
reduced with respect to that for wt SGLT1 (Qmax wt = 25 ± 
5 nC). Cotransport through the last mutant in Group B, 
C292A, appears to be severely perturbed since its Icotr is 
only 20% of the wt Icotr but its Ileak is twice as large. As shown 
in Fig. 6 B, the leak current of C292A becomes larger 
than its cotransport current at potentials more negative 
than −90 mV. As the reduced Icotr seen for C292A, C522A, 
and C560A could be due to a large decrease in sugar af-
fi  nity, the Km
αMG of these mutants were measured. They 
were found to be even smaller than that for wt SGLT1 (in 
mM: 0.27 ± 0.01 for C292A, 0.71 ± 0.06 for C522A, 0.38 ± 
0.1 for C560A, and 0.97 ± 0.1 mM for wt SGLT1). We 
tested the effect of DTT on mutants C560A and C610A, 
and their V1/2 was also shifted by   approximately +25 mV 
for mutant C560A and about +45 mV for C610A, indicat-
ing that these two cysteines were not responsible for the 
observed effect of DTT on V1/2 of wt SGLT1.
Figure 3.  A modifi  ed topological model of SGLT1. Transmem-
brane segments are identifi  ed by Roman numerals, amino acid 
positions of endogenous cysteine residues, depicted in white 
  circles, are indicated and the extracellular and intracellular side 
are indicated by the words “out” and “in,” respectively.
Figure 4.  Western blot analysis of some selected mutants, com-
pared with wt SGLT1, detected with an anti-myc antibody. 
Extracts enriched in plasma membrane were purifi  ed from non-
injected oocytes (A), wt SGLT1–injected oocytes (B), and mu-
tants C345A (C), C351A (D), C355A (E), and C361A (F) and 
double mutant C522,560A (G) and were loaded onto a polyacryl-
amide gel (equivalent to membranes from 20 oocytes), and pro-
tein equivalencies were confi   rmed by Ponceau Red staining. 
Molecular standard masses are indicated on the left (in kD) 
(New England Biolabs).
Figure 5.  Electrophysiological characteristics of mutants classi-
fi  ed in Group A, as compared with wt SGLT1. (A) Comparison of 
mutant SGLTs activities to that of wt SGLT1. Maximal αMG co-
transport (Icotr at 5 mM αMG) and Na+ leak (Ileak) currents were 
measured at −110 mV. The dotted lines indicate the mean 
  expression level of wt SGLT1. n ≥ 5 for each mutant. (B) Off 
  response of presteady-state currents (Pz-sensitive currents in the 
absence of glucose) of typical oocytes expressing each of the 
  mutant SGLT1s compared with an oocyte expressing wt SGLT1. 
(C) V1/2 of mutant SGLT1s as compared with that of wt SGLT1. 
A dotted box represents the interval for which V1/2 of a mutant 
would not be signifi   cantly different from that of wt SGLT1. 
Errors are SEM. Asterisks indicate the statistical signifi  cance with 
respect to wt SGLT1 (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001).150 Disulﬁ  de Bridge in SGLT1
Finally, the two remaining mutants, C255A and 
C511A, comprise Group C. As shown in Fig. 7 A, these 
mutants share the characteristics of wt SGLT1 in the 
presence of DTT, such as a reduced Ileak. The V1/2 of 
mutant C255A was −24 ± 2 mV (n = 8) and −27 ± 2 mV 
(n = 4) for C511A, which is not signifi  cantly different 
from the V1/2 of wt SGLT1 in the presence of DTT 
(−21 ± 1 mV, n = 6). The two mutants were insensi-
tive to DTT treatment with respect to V1/2 (no further 
shift) and Ileak (remained identical to the Ileak observed 
before DTT treatment). The time constants, shown in 
Fig. 7 D, are characterized by their plateau value at 
 4.5 ms. These values are remarkably similar to the 
time constants characterizing wt SGLT1 exposed to 
DTT (see Fig. 2 C).
αMG Afﬁ  nities of Certain Mutants
Other functional characteristics can be used to help 
identify cysteine residues involved in disulfi  de bridges. 
Echoing Fig. 1 C, Fig. 8 shows that the DTT increased the 
Km
αMG of wt SGLT1 from 0.97 ± 0.1 mM to 1.6 ± 0.1 mM 
(as measured at −150 mV). Interestingly, the two mu-
tants of Group C (C255A and C511A) have Km
αMG values 
very similar to that of DTT-treated wt SGLT1 (in mM: 
1.5 ± 0.1 for C255A and 1.6 ± 0.2 for C511A).
Identiﬁ  cation of Pairs of Cysteine Residues Possibly 
Forming a Disulﬁ  de Bridge
The data shown in Figs. 6 and 7 already suggest specifi  c 
pairs of cysteine residues that could be involved in di-
sulfi  de bridges. The most obvious pair is from Group C 
where replacing C255 and C511 generate functional 
effects that closely mimic the effect of DTT. This is true 
for the positive shift in V1/2, the acceleration of the 
presteady-state currents and the reduced proportion 
between Ileak and Icotr. Within Group B, the identifi  ca-
tion of interesting cysteine residues pairs is less straight-
forward. Mutants C314A, C522A, and C560A had very 
similar V1/2 values. Of these three mutants, C522A and 
C560A also exhibited similar reduction in levels of ex-
pression. Consequently, double mutants were pro-
duced involving the pairs of amino acids residues 
314,560 and 522,560. The pair 560,610 was also stud-
ied because these two cysteines have previously been 
postulated to form a disulfi  de bridge in an isolated 
loop in rabbit SGLT1 (Xia et al., 2003, 2004) and this 
hypothesis had not yet been tested using the complete 
and functional protein. We also studied other pairs of 
mutants under the assumption that C610 could be 
forming a disulfi   de bridge with a different partner 
than the one proposed by Xia et al. (2003, 2004). The 
Figure 6.  Electrophysiological character-
istics of mutants classifi  ed in Group B, as 
compared with wt SGLT1. (A) Compari-
son of mutant SGLT1 activities to that of wt 
SGLT1. Maximal αMG cotransport (Icotr at 
5 mM αMG) and Na+ leak (Ileak) currents 
were measured at −110 mV. The dotted 
lines indicate the mean expression level of 
wt SGLT1. n ≥ 5 for each mutant. (B) I-V 
curve for αMG cotransport and Na+ leak 
currents of C292A. (C) Off response of 
presteady-state currents (Pz-sensitive cur-
rents in the absence of glucose) of typi-
cal oocytes expressing each of the mutant 
SGLT1s. (D) V1/2 of mutant SGLT1s as 
compared with that of wt SGLT1. A dot-
ted box represents the interval for which 
V1/2 of a mutant would not be signifi  cantly 
different from that of wt SGLT1. Errors 
are SEM. All V1/2 values for this series 
of mutants were signifi  cantly  different 
(P < 0.001 in each case) from the V1/2 of 
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most logical partners (292 and 301) were the cysteines 
that had the most important shift in V1/2 as compared 
with wt SGLT1.
Double Mutants
In creating double mutants to check for the presence of 
a disulfi  de bridge, we sought instances where the effect 
of a single cysteine replacement on a given parameter 
would vanish if its partner cysteine residue had already 
been replaced. Six double mutants were generated. Un-
fortunately, the double mutant C522,560A was not func-
tional even though it was present as observed by Western 
blot (Fig. 4, lane G). The other double mutants 
(C255,511A, C314,560A, C560,610A, C292,610A, and C301,610A) 
were functional and the amplitude of their αMG co-
transport currents (Icotr) and Na+ leak currents (Ileak) at 
−110 mV (Fig. 9 A), as well as their V1/2 values (Fig. 9 C) 
were compared with those of wt SGLT1. (The name of 
double mutants was shortened for clarity in fi  gures. For 
example, the symbol C255,511A means that the cysteines 
in positions 255 and 511 were both mutated into an ala-
nine residue.)
In two cases, the effects of each mutations on V1/2 
were roughly additive. This is the case of C292,610A and 
C301,610A. Analysis of Fig. 9 C indicates that mutating 
C610 to an alanine residue produces a powerful nega-
tive shift in V1/2 by  75 mV independent of the pres-
ence of C292 or C301. The double mutant C292,610A 
retains the large Ileak of the individual, single mutants 
while the Icotr is completely abolished for 5 mM αMG 
Figure 7.  Electrophysiological character-
istics of mutants classifi  ed in Group C, as 
compared with wt SGLT1, with and with-
out DTT. (A) Comparison of mutant 
SGLT1s activities to that of wt SGLT1 and 
to wt SGLT1 + DTT. Maximal αMG co-
transport (Icotr at 5 mM αMG) and Na+ leak 
(Ileak) currents were measured at −110 mV. 
The dotted lines indicate the mean expres-
sion level of wt SGLT1. n ≥ 5 for each mu-
tant. (B) Off response of presteady-state 
currents (Pz-sensitive currents in the ab-
sence of glucose) of typical oocytes ex-
pressing wt SGLT1 exposed to DTT and 
mutants C255A and C511A. (C) V1/2 of 
mutant SGLT1s as compared with that of 
wt SGLT1 (fi  lled bars) and to wt SGLT1 
and mutants exposed to DTT (open bars). 
The dotted box represents the interval for 
which V1/2 of a mutant would not be signif-
icantly different from that of wt SGLT1. 
(D) Time constants of the slow component 
of presteady-state currents for mutants of 
Group C. The curves represent the time 
constants evaluated with a four-state model 
of presteady-state currents with parame-
ters described in Table I. Errors are SEM.
Figure 8.  Apparent affi  nity for αMG (Km
αMG) for oocytes express-
ing mutants C255A, C511A, and C255,511A compared with wt SGLT1, 
with and without DTT. The application of DTT to wt SGLT1 was 
performed as described in MATERIALS AND METHODS (paired 
experiments). The affi  nity was assessed with data measured at −150 
mV. The dotted box represents the interval for which the Km
αMG 
of a mutant would not be signifi  cantly different from that of wt 
SGLT1. The number of individual oocytes used per value is indi-
cated in   parentheses. Errors are SEM. Stars indicate the statistical 
signifi  cance (see Fig 5 legend).152 Disulﬁ  de Bridge in SGLT1
C610 only produces a shift of V1/2 by 50 mV. To put it 
another way, the single C560A mutation produced a 
shift of V1/2 by −30 mV when compared with wt SGLT1 
but the effect of the double mutant is only −6 mV when 
compared with the single mutant C610A. A qualitatively 
similar comparison can be done with mutations C314A 
and C560A. The effect of introducing either mutation 
is signifi  cantly reduced when they are performed after 
the other cysteine residue has been replaced. In these 
two cases (C560,610A and C314,560A), other parameters 
have to be considered before suggesting the presence 
of disulfi  de bridges. Fig. 6 A shows that replacing C560 
produces a reduction of Icotr by 63% while the Icotr reached 
with C314A and C610A are equal or larger than the wt 
level. It appears that the effect of C560 replacement 
on the activity level is conserved when it is performed 
alongside alanine substitution of C314 or of C610 (80% 
and 75% reduction with respect to C314A and C610A, 
respectively, see Fig. 6 A and Fig. 9 A). This is not what 
would be expected if the effect of C560 replacement 
Figure 9.  Electrophysiological characteristics of the double mutants as compared with wt SGLT1. (A) Comparison of mutant SGLT1 
  activities to that of wt SGLT1. Maximal αMG cotransport (Icotr at 5 mM αMG) and Na+ leak (Ileak) currents were measured at −110 mV. 
The dotted lines indicate the mean expression level of wt SGLT1. n ≥ 5 for each mutant. (B) I-V curve for αMG cotransport and 
Na+ leak currents of the double mutant C292,610A. (C) V1/2 of double mutant SGLTs as compared with that of wt SGLT1 and to single 
  mutants. Each double mutant bar (black) is preceded and followed by the two bars representing the V1/2 values for the corresponding 
single mutants (light gray). The dotted box represents the interval for which V1/2 of a mutant would not be signifi  cantly different from 
that of wt SGLT1. (D) Time constants of the slow component of presteady-state currents for the double mutant C255,511A (see Fig 7). 
(n  = 5). The curve represents the time constants evaluated with a four-state model of presteady-state currents with parameters 
described in Table I. Errors are SEM.
(Fig. 9 B) and no current could be induced by the addi-
tion of either 25 or 100 mM αMG (not depicted). 
In contrast, when C560 is mutated to an alanine, replacing 
TABLE I
Rate Constant of the Four-state Kinetic Model Used for the Calculations 
of Time Constants and Transferred Charges of wt SGLT1 and Mutants
k120 a k210 k230 k320 k340 k430 k410 b V1/2 c
s−1 s−1 s−1 s−1 M−1s−1 s−1 s−1 mV
wt SGLT1 790 370 100 180 8000 2300 10 −39
wt + DTT, 
 C255A,  C511A, 
 and  C255,511A 790 370 230 180 8000 2300 10 −20
aThe constant k120 (as well as other kij0) represents the value of k12 (and kij) 
at 0 mV.
bThe constant k140 (in s−1M−1) was calculated in order to respect the micro 
reversibility as described in Appendix A.
cThe V1/2 was obtained from a fi  t of a Boltzmann relation to the Q-V curve 
calculated with the model as described in Appendix B. The experimental 
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was due to the disruption of disulfi  de bridges with C314 
or C610.
Finally, the double mutant C255,511A had an activity 
level (Fig. 9 A), a time constant for presteady-state cur-
rents (Fig. 9 D), and a V1/2 (Fig. 9 C) similar to the sim-
ple mutants C255A and C511A. With respect to the 
effect on V1/2, it is clear that the effect of introducing 
  either of the single mutants (a shift by +20 mV) is lost 
when the other cysteine residue has already been re-
placed (compare the effect of C255,511A to the effect of 
each of the single mutants in Fig. 9 C). Moreover, 
C255A, C511A, and C255,511A are insensitive to DTT as 
their V1/2 values remain unchanged by treatment with 
10 mM DTT (Fig. 7 C for simple mutant, not shown for 
C255,511A). The presence of a disulfi  de bridge between 
C255 and C511 is also supported by the observation 
that, in the double mutant, Km
αMG was the same as that 
for each of the simple mutants C255A and C511A, which 
is also very similar to that of wt SGLT1 in the presence 
of DTT (see Fig. 8).
Fluorescent Labeling of C255 and C511
To complement studies examining the function of 
SGLT1 mutants and to further test the hypothesis that 
C255 and C511 could form a disulfi  de bridge, we used 
fl  uorescent labeling as an independent test of available 
cysteine residues in the mutant proteins. We incubated 
the C255A- and C511A-expressing oocytes with saline 
solution containing the fl  uorescent probe tetramethyl-
rhodamine-5-maleimide (TMR5M, see MATERIALS 
AND METHODS). Fig. 10 shows the fl  uorescent signal 
of labeled oocytes expressing mutant C511A (TMR5M 
putatively attached to C255) and of mutant C255A 
(TMR5M putatively attached to C511) as compared 
with wt SGLT1 and to the double mutant C255,511A in 
which no cysteine appears to be available for labeling. 
This indicates that the two simple mutations (C255A 
and C511A) allow the fl  uorescent probe to access a cys-
teine that is not accessible in the double mutant 
(C255,511A) or in wt SGLT1 and strongly supports the 
  hypothesis of a disulfi  de bridge between these two cys-
teine residues in SGLT1.
DISCUSSION
In SGLT1 only 5 of the 15 endogenous cysteine resi-
dues are located in putative transmembrane segments 
(TMS VII, VIII, and XIV), with the majority located 
in extracellular loops (loop 6–7, loop 8–9, loop 12–13) 
and in the special, putatively reentrant loop 13–14 (Lin 
et al., 1999; Gagnon et al., 2005). Eight of these cyste-
ine residues (C255, C292, C345, C351, C355, C361, 
C511, and C610) are conserved amongst SGLT1, 
SGLT2, SGLT3, SMIT1, and SMIT2. Amongst those, 
C351 is conserved across nearly the entire SLC5 family. 
Some other residues are conserved among the SGLT1, 
2, and 3 isoforms (C301, C314, C317, C517, C522, and 
C560). In contrast, C659 is present only within the 
SGLT1 isoforms. This high degree of cysteine conserva-
tion suggests that they may play a role either in a spe-
cifi  c function or in the general structure (or both) of 
the Na+-coupled cotransporters of SLC5 family. It has 
been shown before that wt SGLT1 is not sensitive to al-
kylation (NEM nor MTS reagents) (Loo et al., 1998; Lo 
and Silverman, 1998a; Gagnon et al., 2005). This means 
that these reagents can bind to some cysteine residues 
without producing any functional effect or, alterna-
tively, that no cysteine residues are available to these re-
agents because the residues are buried in the membrane, 
involved in disulfi  de bridges or inaccessible to the sol-
vent. The fact that the degree of fl  uorescent labeling of 
wt SGLT1 with TMR5M is identical to the basal fl  uores-
cent labeling obtained with noninjected oocytes sup-
ports the latter possibility. Although the roles of the 
endogenous cysteine residues in SGLT1 have never 
been studied in detail, a few reports have suggested im-
portant roles for, at least, some of them in protein traf-
fi  cking (Martin et al., 1996; Wright, 1998; Xia et al., 
2003, 2004).
Figure 10.  Fluorescent labeling of oocytes expressing mutants 
C255A, C511A, and C255,511A as compared with wt SGLT1. See 
  MATERIALS AND METHODS for the procedure of fl  uorescent 
labeling with the TMR5M fl  uorescent probe. The fl  uorescence 
signal is indicated in arbitrary units (a.u.). NI indicates nonin-
jected oocytes. The number of oocytes used per sample is indi-
cated in parentheses. A cartoon shows the availability of cysteine 
residues in each situation. Stars indicate the statistical signifi  cance 
for unpaired Student’s t test against wt SGLT1 data (see Fig 5 
  legend). Errors are SEM.154 Disulﬁ  de Bridge in SGLT1
Presteady-state currents involving SGLT1 can be 
observed in the absence of glucose. They were fi  rst 
observed shortly after the cloning of SGLT1 which, 
through expression in Xenopus oocytes, enabled its 
precise characterization using the two microelectrode 
voltage-clamp technique (Umbach et al., 1990; Parent 
et al., 1992a,b). The model proposed by Parent et al. 
(1992a,b) was revisited using the cut-open oocyte tech-
nique, providing the observation of a faster component 
of presteady-state currents (Chen et al., 1996). A slower 
time constant was also postulated recently (Krofchick 
and Silverman, 2003; Loo et al., 2005). As illustrated 
in Fig. 11, presteady-state currents arise from the volt-
age-dependent empty carrier translocation (C1↔C2↔
C3) and from voltage-dependent Na+ binding–debind-
ing (C3↔C4(Na+)). Integration of these currents corre-
sponds to the quantity of transferred charge that can be 
approximated (as a function of membrane potential) 
by a Boltzmann equation. Two parameters of presteady-
state currents were examined to compare normal and 
mutant SGLT1: V1/2, the voltage at which half of the 
charge is transferred and the  10 ms time constant 
(described by Loo et al., 1993; Chen et al., 1996) arising 
from the modulated transition between C1 to C4(Na+). 
The faster time constant could not be accurately re-
solved by two-microelectrode voltage-clamp.
DTT Effect on wt SGLT1 Activity
We report in the present study the sensitivity of SGLT1 
steady-state and presteady-state currents to a reducing 
agent, DTT, which is assumed to break all disulfi  de 
bridges even if they are buried within the membrane 
(Cleland, 1964). The steady-state parameters (Ileak and 
Icotr) were not similarly affected by DTT exposure: Ileak 
was reduced whereas Icotr was not affected at all. The 
Km
αMG was increased by 60% without any change in its 
voltage dependence (Fig. 1 C). According to the cur-
rent model (see below), these effects are consistent with 
a shift in the conformational equilibrium toward an 
outward facing confi  guration of the transporter. As the 
affi  nity for sugar depends on a large number of param-
eters, it is diffi  cult at this point to propose any specifi  c 
change produced by DTT in the transporter mecha-
nism to explain the rise of Km
αMG. In contrast, presteady-
state currents were greatly affected by DTT as the Q-V 
curve was shifted by +25 mV (Fig. 2 B) and the time 
constants were accelerated (Fig. 2 C). Compared with a 
parameter such as Km
Nα+, the V1/2 of the Q-V curve de-
pends on a smaller set of rate constants and was there-
fore chosen as our principal criterion for classifying the 
mutated forms of SGLT1 for identifying the disulfi  de 
bridge(s) responsible for the effects of DTT.
Nonfunctional Mutants
Mutants C351A, C355A, and C361A, located in the extra-
cellular loop between TMS VIII and IX, and the double 
mutant C522,560A were nonfunctional: they exhibited no 
presteady-state currents, no Ileak nor Icotr (5 mM αMG or 
100 mM αMG, unpublished data). However, we could de-
tect the presence of SGLT1 on Western blots using prep-
arations enriched in plasma membranes. As mutants 
C351A and C361A were shown not to be traffi  cked to the 
plasma membrane (Xia et al., 2005), we suggest that 
these mutants are also retained within intracellular com-
partments and confi  rm that C351 and C361 are impor-
tant in the correct traffi  cking to the plasma membrane.
Expression of Single Mutants
The characteristics of the single mutants presented in 
this study suggest that endogenous cysteine residues in 
SGLT1 are involved in important aspects of protein 
function: proper traffi  cking to the plasma membrane 
(as suggested by the nonfunctional mutants and by 
some weakly expressed mutants) and maintaining the 
voltage sensor in either the inward or outward confi  gu-
rations (as suggested by mutants in Group B and C). 
Only three cysteines could be removed without any 
prominent effect on the function of the transporter 
(C317A in TMS 8, C517A in loop 12–13, and C659A in 
the last TMS). These results are similar to those ob-
tained with other cotransporters, which also suggested a 
role for endogenous cysteines in the proper traffi  cking 
of proteins to the plasma membrane (J.G. Chen et al., 
1997; Sur et al., 1997; Pajor et al., 1999; Tanaka et al., 
2004). However, none of the endogenous cysteines pre-
viously studied in other cotransporters has been re-
ported to play a role in presteady-state currents. The 
fi  rst round of mutation identifi  ed C255 and C511 as 
  being potentially involved in a disulfi  de bridge.
Expression of Double Mutants
To identify a disulfi  de bridge, the mutants of Group A 
were discarded because the V1/2 of their Q-V curve was 
not signifi  cantly different from that of wt SGLT1 under 
control conditions. Then mutants whose V1/2 was 
  affected were classifi  ed into two categories: those with 
Figure 11.  Kinetic model of the Na+/glucose cotransporter 
states for the estimation of presteady-state currents. The model 
was previously described in Chen et al. (1996). See Appendices 
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Q-V curves shifted toward negative potentials (Group 
B) and those which were shifted toward positive poten-
tials (Group C).
As a fi  rst observation, all mutants in Group B display 
distinctly different characteristics, except for C522A 
and C560A, which were indistinguishable in terms of 
V1/2, Icotr, and Ileak. However, the double mutant C522,560A 
did not generate any cotransport activity. As both C522A 
and C560A presented reduced activity in terms of Icotr 
and Ileak (20–30% of wt SGLT1), the absence of func-
tional activity for the double mutant could be inter-
preted as though the effects of the two mutations were 
additive. This is not what would be expected if C522 
and C560 were linked through a disulfi  de bridge.
The additive effect can also be seen with other mu-
tants; for instance, the mutant C314,560A displays half 
the Icotr seen with the single mutant C314A while the Ileak 
and the V1/2 remain normal, similar to the effects of 
the single mutant C560A. This reduced Icotr also oc-
curred in the double mutant C560,610A. This was the fi  rst 
double mutant produced in this study because these 
two cysteines have been postulated to be involved in 
a disulfi  de bridge in an isolated loop in rabbit SGLT1 
(Xia et al., 2003, 2004). Our results do not support this 
hypothesis as the V1/2 associated with the double mu-
tant seems to be controlled by the C610A mutation 
while the activity level seems to be controlled by the 
C560A mutation. Moreover, the Q-V curves of these 
two mutants are still shifted toward positive potential 
by DTT, similarly to wt SGLT1.
The double mutant C292,610A is very interesting since 
it has no αMG cotransport whereas its Ileak is as large as 
those of the singly mutated forms of SGLT1. The ab-
sence of Icotr was not due to a simple decrease of αMG 
affi  nity for its binding site since the Km
αMG values for the 
single mutants were similarly low (0.27 ± 0.01 mM for 
C292A and 0.28 ± 0.02 mM for C610A). Interestingly, 
Pz still inhibits the Ileak and presteady-state currents. 
We cannot state that these cysteines form a disulfi  de 
bridge because of the effects observed with the double 
mutant. However, it suggests that these two cysteines, 
together, somehow play a role in coupling Na+ and 
glucose transport.
Disulﬁ  de Bridge between C255 and C511
To date, intramolecular disulfi   de bridges have been 
identifi  ed for only a few transporters. The endogenous 
cysteine residues of Na+/Pi cotransporter type IIa have 
been studied in detail using mutagenesis, Western blot, 
and by examining the effects of the reagents TCEP and 
MTS on transport (Lambert et al., 2000; Kohler et al., 
2003); an essential disulfi  de bridge between two cyste-
ines, which are located in the same extracellular loop, 
has been identifi  ed and another was postulated. These 
are responsible for the TCEP (another reducing agent) 
sensitivity of the transporter. The serotonin transporter 
(SERT) contains 16 endogenous cysteines of which 
three are conserved throughout the NaCl-coupled neu-
rotransmitter transporter family (Chen et al., 1997; Sur 
et al., 1997). Characterization of the transport pro-
perties of SERT mutants have identifi  ed functionally 
important cysteines as well as a disulfi  de bridge between 
two conserved cysteines, also located on the same extra-
cellular loop.
The similarity of the V1/2 values of the mutants in 
Group C (C255A and C511A, located in extracellular 
loops 6–7 and 12–13, respectively) with that of reduced 
wt SGLT1 is remarkable (Fig. 2 D, Fig. 7 D, and Fig. 
9 D). It suggests that these two cysteines are, in fact, co-
valently bound by a disulfi  de bridge and that its break-
age affects the V1/2. The V1/2 of both of these mutants 
are also DTT insensitive. The double mutant C255,511A 
supports this hypothesis as its V1/2 is the same as those 
of the simple mutants, and it is also insensitive to DTT. 
As another functional test, we measured the apparent 
affi  nity for αMG for these mutants. The three mutants 
C255A, C511A, and C255,511A also exhibit a Km
αMG value 
similar to that of wt SGLT1 under reducing conditions. 
We showed that SGLT1 (when C511 had been mutated 
into alanine or when C255 had been mutated into ala-
nine) could be labeled by a fl  uorescent probe and that, 
in the absence of both cysteines (in mutant C255,511A), 
no labeling could be achieved (Fig. 10). Taken together, 
these results strongly support the disulfi  de bridge hypo-
thesis. We also demonstrated that the disruption of the 
bridge affects the function of the protein, changing the 
equilibrium voltage for the proposed negatively charged 
binding site (V1/2) and thus affecting the Na+ current 
in the absence of glucose (Ileak) and the apparent affi  n-
ity for glucose (Km
αMG).
Kinetic Model of Presteady-state Currents
The simple four-state kinetic model proposed by Chen 
et al. (1996) and illustrated in Fig. 11 (see also Table I 
for kij values and for deduced V1/2), was used to model 
the time constants and transferred charges. The princi-
pal equations describing this model are given in Appen-
dices A and B. The model explains the time constants of 
presteady-state currents (curves in Fig. 2 C for wt SGLT1, 
Fig. 7 D for C255A and C511A, and Fig. 9 D for C255,511A) 
and transferred charges, allowing the fi  t of a theoretical 
Q-V curve with a simple Boltzmann curve to extract 
V1/2. Parameter values proposed by Chen et al. (1996) 
were slightly modifi  ed to fi  t wt SGLT1 time constant and 
Q-V curves obtained in double microelectrode electro-
physiology. The values of zi used for the equivalent 
charge moving across the entire membrane electrical 
fi  eld in the step between state “i” and “i+1” were −0.4, 
−0.35, −0.6, and 0, while the values for αi describing 
the asymmetry of the energy barrier were 0.3, 0, 0.4, and 
0 for i going from 1 to 4, respectively. If it is assumed 
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moving in the membrane electrical fi  eld, these values of 
zi would indicate that the charge is crossing 40% of the 
electrical fi  eld in the reaction linking C1 to C2 and 35% 
between C2 and C3. In the Na+ binding reaction, the 
equivalent of one positive charge would cross 60% of 
the membrane electrical fi  eld. This could be due to the 
movement of Na+, the movement of the negative charge 
attached to the binding site, or a combination of both. 
The set of proposed rate constants for wt SGLT1 in 
Table I would lead to occupancy probability (Ci) of 0.07, 
0.31, 0.31, and 0.31 (from i = 1 to 4) at −50 mV.
We thus achieve a V1/2 of −39 mV for Q-V curve with 
satisfying time constants as a function of Vm for wt 
SGLT1. To obtain the one of wt SGLT1 in the presence 
of DTT, we had to increase k230 by a factor 2.3 to ac-
count for the faster time constants observed for the pre-
steady-state current at hyperpolarizing potentials. This 
sole change affected both the plateau of the time con-
stants at hyperpolarizing potential and the V1/2, reach-
ing −20 mV, without any change in the apparent valence 
of the Boltzmann curve (unpublished data), which is in 
agreement with the observations. These changes also 
correctly fi  t to the mutants characteristics.
Even though this disulfi  de bridge is not essential for 
the function of SGLT1, since removing it did not prevent 
the transporter from being functional at the plasma 
membrane, it greatly infl  uenced the equilibrium position 
of transferred charges. The disulfi  de bridge described in 
other transporters has had no such important role.
Conclusion
With the presence of 15 endogenous cysteine residues 
in SGLT1, 105 different combinations exist for creating 
a disulfi  de bridge. In the present study, we have pre-
sented an approach that allows one to positively identify 
a specifi  c disulfi  de bridge without having to test all of 
the possibilities. Our results suggest important roles for 
cysteine in SGLT1: proper traffi   cking to the plasma 
membrane and maintenance of the voltage sensing part 
of the protein in the inward or outward facing confi  gu-
ration. We also identifi  ed a functionally important disul-
fi  de bridge, between C255 and C511 of human SGLT1, 
which is responsible for the effects of DTT on the trans-
ferred charges of wt SGLT1, and which affects the volt-
age-independent conformation change from state C2 
to C3. The identifi  cation of a disulfi  de bridge in SGLT1 
(and possibly in SGLT2 and 3 and in SMIT1 and 2 where 
these residues are conserved) provides a direct, three-
dimensional constraint to the structure of the trans-
porter and to the organization of some transmembrane 
segments. If amino acids 255 and 511 are closer than 
2.05 Å from each other (Loerger, 2005), it indicates that 
TMS VI and VII are close to TMS XI, XII, and XIII. To 
our knowledge, this is the fi  rst direct experimental evi-
dence of a physical constraint between two distant 
amino acid positions in SGLT1.
APPENDIX
A. Expressions for Rate Constant and Time Constants
The four-state kinetic model from Chen et al. (1996) 
was used to model the effects of DTT on wt SGLT1 and 
to examine the characteristics of mutants C255A, 
C511A, and the double mutant C255,511A (see Figs. 2, 7, 
and 9 for experimental and simulated curves, Fig. 11 for 
the scheme of the model, and Table I for the values of 
kij0 and of the deduced V1/2). For all of the simulations, 
[Na+
out] and [Na+
in] were fi  xed at 90 mM and 7 mM, 
respectively. See D  I  S  C  U  S  S  I  O  N   for other values.
The following equations were used to calculate time 
constants occurring for different membrane potentials:
12 120 1 1 exp
FV
kk z
RT
⎛⎞
⎜⎟
⎝⎠
     
() 21 210 1 1 exp 1
FV
kk z
RT
⎛⎞
⎜⎟
⎝⎠
           
23 230 2 2 exp
FV
kk z
RT
⎛⎞
⎜⎟
⎝⎠
     
() 32 320 2 2 exp 1
FV
kk z
RT
⎛⎞
⎜⎟
⎝⎠
            (1)
34 340 3 3 exp out
FV
kkN a z
RT
⎛⎞ ⎡⎤ ⎜⎟ ⎣⎦ ⎝⎠
       
() 43 430 3 3 exp 1
FV
kk z
RT
⎛⎞
⎜⎟
⎝⎠
           
41 410 4 4 exp ,
FV
kk z
RT
⎛⎞
⎜⎟
⎝⎠
     
where zi represents the charge valence (equivalent 
charge moving across the whole membrane), αi (rang-
ing between 0 and 1) describes the asymmetry of the 
energy barriers, V is the membrane potential, and F, T, 
and R have their usual meanings. To assure microscopic 
reversibility, the last constant k140 was calculated to have 
no net transport at 0 mV with no Na+ gradient:
120 230 340 410
140
430 320 210
kkkk
k
kkk
⎛⎞
⎜⎟
⎝⎠
    (2)
() 14 140 4 4 exp 1 in
FV
kkN a z
RT
⎛⎞ ⎡⎤⎜⎟ ⎣⎦⎝⎠
            
Certain approximations, satisfi  ed in our case and de-
scribed in Chen et al. (1996), allowed us to establish the 
slow time constant and to determine the following 
expression for τslow:
()
12
12
12 21
k
f
kk
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()
43
43
34 43
k
f
kk
   
   
(3)
12 23 43 32
1
slow fk fk
     
   
B. Expressions for Transferred Charges
Variations in time of the probability of fi  nding trans-
porters in each state are calculated as usual, for the 
  desired membrane potential, with a given fi  rst value:
2
2 21 1 12 2 23 3 32
dC
Ck Ck Ck Ck
dt
                
3
33 2 22 3 33 4 44 3
dC
Ck Ck Ck Ck
dt
                
4
44 3 33 4 44 1 11 4 .
dC
Ck Ck Ck Ck
dt
             
They were multiplied by the time increment and this 
variation was added to the previous value:
i
i
dC
Cd t
dt
     
1 , ii i tt CC C
           (4)
where Ci represents the probability of occupation of 
state i in the model (see Fig. 11), but to conserve the 
  total probability of transporters at unity, C1 is calculated 
as followed:
() 12 3 4 1 CC C C                 (5)
We set the charge to be zero at extreme hyperpolariz-
ing potentials (as C4 = 1 and C3 = C2 = C1 = 0) by use 
of the following equation:
  () ( ) 33 2 2 3 1 1 2 3  . QC zC zz C zz z                          (6)
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